Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 5/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 5/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 4/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 4/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10376272 | 1.00 | CHRNB2 (0.34) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7 | |
| Hydrochloric Acid SCHEMBL10377421 | 0.98 | CHRNB2 (0.33) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7 | |
| Hydrochloric Acid SCHEMBL10377423 | 0.98 | CHRNB2 (0.33) | CHRNB2CHRNA4CHRNB4CHRNA3CHRNA7 | |
| Fluparoxan SCHEMBL7173629 | 0.81 | SLC6A2 (0.38) | CHRNB2CHRNA4CHRNA7SLC6A2SLC6A3 | |
| Fluparoxan SCHEMBL9570339 | 0.81 | SLC6A2 (0.38) | CHRNB2CHRNA4CHRNA7SLC6A2SLC6A3 | |
| Fluparoxan SCHEMBL112164 | 0.81 | SLC6A2 (0.38) | CHRNB2CHRNA4CHRNA7SLC6A2SLC6A3 | |
| Fluparoxan SCHEMBL122268 | 0.79 | HTR6 (0.38) | CHRNB2CHRNA4CHRNA7SLC6A2SLC6A3 | |
| Fluparoxan SCHEMBL9482026 | 0.79 | HTR6 (0.38) | CHRNB2CHRNA4CHRNA7SLC6A2SLC6A3 | |
| Fluparoxan SCHEMBL9482018 | 0.79 | HTR6 (0.38) | CHRNB2CHRNA4CHRNA7SLC6A2SLC6A3 | |
| Hydrochloric Acid SCHEMBL10376293 | 0.76 | HTR2A (0.31) | SLC6A2SLC6A3SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0162593-B1 | HETEROCYCLIC AMINO COMPOUNDS | GLAXO GROUP LIMITED (GB) | 1990-08-16 | — | — | EP | claimed |
| US-4880801-A | ALPHA 2-ADRENORECEPTOR ANTAGONIST | GLAXO GROUP LIMITED (GB) | 1989-11-14 | — | — | US | claimed |
| EP-0162593-A1 | Heterocyclic amino compounds | GLAXO GROUP LIMITED (GB) | 1985-11-27 | — | — | EP | claimed |
| EP-0162593-B1 | HETEROCYCLIC AMINO COMPOUNDS | GLAXO GROUP LIMITED (GB) | 1990-08-16 | — | — | EP | disclosed |
| US-4880801-A | ALPHA 2-ADRENORECEPTOR ANTAGONIST | GLAXO GROUP LIMITED (GB) | 1989-11-14 | — | — | US | disclosed |